Current Problems in Cancer

Papers
(The TQCC of Current Problems in Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Oncolytic virotherapy: Challenges and solutions59
Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer56
CAR T-cell therapy for B-cell lymphoma43
Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges42
Fibrolamellar carcinoma: An entity all its own30
Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors26
Chordoma: Current status, problems, and future directions26
Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer25
Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae22
Exosomal microRNA panels as biomarkers for hematological malignancies21
Monoclonal antibody based radiopharmaceuticals for imaging and therapy20
Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea18
Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysis17
Vaginal intraepithelial neoplasia in patients after total hysterectomy17
Advances in the management of alveolar soft part sarcoma16
Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies16
Risk of lymph node metastasis and prognostic outcome in early gastric cancer patients with mixed histologic type16
The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study15
Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients15
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies – An evidence-based review14
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer14
Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review14
Clinical features and prognostic impact of TCF3–PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China13
Tisotumab vedotin in recurrent or metastatic cervical cancer13
Disparities in cancer screenings for sexual and gender minorities12
Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends11
The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer11
Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review11
Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis10
Using real world data to support regulatory approval of drugs in rare diseases: A review of opportunities, limitations & a case example10
Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study10
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib10
A targeted approach to phosphoinositide-3-kinase/Akt/mammalian target of rapamycin-induced hyperglycemia10
EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management9
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report9
Chemotherapy and immune check point inhibitors in the management of cervical cancer9
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysis9
Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors9
Prognostic value of visceral pleural invasion in the stage pT1-2N2M0 non-small cell lung cancer: A study based on the SEER registry8
Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature8
Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization8
Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literature8
Mucocele-like lesions of the breast - A radiological and clinicopathological analysis7
Cancer during a pandemic: A psychosocial telehealth intervention for young adults7
Social determinants of health, workforce diversity, and financial toxicity: A review of disparities in cancer care7
Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study7
Integration of geriatric assessment into clinical oncology practice: A scoping review7
Selinexor in patients with advanced and recurrent endometrial cancer7
Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients7
Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis7
Novel approaches for treatment of endometrial carcinoma7
Severe mental illness in cancer is associated with disparities in psycho-oncological support7
Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy7
ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients7
Editorial: Special issue on rare cancers6
Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study6
Recurrence of high-grade vaginal intraepithelial neoplasia after various treatments6
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC6
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure6
QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer6
Kidney cancer: from genes to therapy6
Seasonal influenza vaccination among cancer patients: A systematic review and meta-analysis of the determinants6
Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-0035
Gynecologic and Breast Cancers: What's New in Chemoresistance and Chemosensitivity Tests?5
High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia5
Hyperprogressive disease in patients receiving immune checkpoint inhibitors5
Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis5
Novel prognostic value and potential utility of opioid receptor gene methylation in liquid biopsy for oral cavity cancer5
Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine5
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?5
Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis5
Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer5
Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy5
Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome5
Clinical study of serum IGFBP7 in predicting lymphatic metastasis in patients with lung adenocarcinoma5
Impact of active tuberculosis on treatment decisions in cancer5
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications5
Update on the Role of Imaging in Staging of Common Pediatric Abdominal Tumors5
Urachal carcinoma: A case of a rare neoplasm5
The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database5
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?5
Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors5
The ‘comeback’ of Selinexor: From toxic to tolerable5
0.033590078353882